Jason Rhodes


Jason Rhodes is a partner at Atlas Venture. Jason is the chairman and was the founding chief executive officer of Generation Bio, Dyne Therapeutics (NASDAQ: DYNE), and previously Disarm Therapeutics (acquired by Lilly in 2020). He is on the boards of Replimune (NASDAQ: REPL), Be Biopharma, Gemini Therapeutics, and Accent Therapeutics. Jason rece...


Roles at Generation Bio

  • Chair

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.